We envision a future where medicine is humane, precise, personalized and affordable.
Our mission is to serve humankind through scientific research and teaching.
Our research goal is to understand how gene networks control cell behavior. We focus on important cancer genes.
We are a research-teaching team. We teach in the classroom, in the lab and on social media.
Our first eLIFE paper is out!
May 27, 2014.
Got eLIFE? We do! Our first (but definitely not last) paper in the awesome journal eLIFE is now out for everyone's enjoyment. We report here the first global analysis of p53-regulated transcription using Global Run-On-sequencing (GRO-seq). Kudos to Mary and the rest of the team for working together on this great project. You can check the paper HERE.
Joaquin was invited by the Department of Biology at Indiana University in Bloomington to present the prestigious Holland lecture. Learn more about it here.
Click here to read Joaquin's latest contribution to the Huffington Post, discussing a link between Down Syndrome and cancer.
Kelly Sullivan's paper describing the mechanisms of synthetic lethality between inhibitors of MDM2 and ATM is currently in press at Cell Cycle.
Joaquin presents the Holland Lecture at IU
New Huffington Post Column
Kelly's paper in press
There is no science without fancy and no art without facts.